ATE295168T1 - Zusammensetzung von riluzol und alpha-tocopherol - Google Patents

Zusammensetzung von riluzol und alpha-tocopherol

Info

Publication number: ATE295168T1
Authority: AT; Austria
Prior art keywords: riluzole; tocopherol; alpha; composition; combination
Prior art date: 1998-11-13

Application number

AT99972101T

Other languages

English (en)

Inventor

Michel Dib

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-13

Filing date

1999-11-09

Publication date

2005-05-15

1999-11-09 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2005-05-15 Application granted granted Critical

2005-05-15 Publication of ATE295168T1 publication Critical patent/ATE295168T1/de

Links

GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 title abstract 4
FTALBRSUTCGOEG-UHFFFAOYSA-N Riluzole Chemical group C1=C(OC(F)(F)F)C=C2SC(N)=NC2=C1 FTALBRSUTCGOEG-UHFFFAOYSA-N 0.000 title abstract 3
229940087168 alpha tocopherol Drugs 0.000 title abstract 2
229960004181 riluzole Drugs 0.000 title abstract 2
229960000984 tocofersolan Drugs 0.000 title abstract 2
239000002076 α-tocopherol Substances 0.000 title abstract 2
235000004835 α-tocopherol Nutrition 0.000 title abstract 2
239000002671 adjuvant Substances 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Fats And Perfumes (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
External Artificial Organs (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Anti-Oxidant Or Stabilizer Compositions (AREA)
Cosmetics (AREA)
Saccharide Compounds (AREA)
Treatment Of Liquids With Adsorbents In General (AREA)
Pyrane Compounds (AREA)

AT99972101T 1998-11-13 1999-11-09 Zusammensetzung von riluzol und alpha-tocopherol ATE295168T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9814250A FR2785808B1 (fr)	1998-11-13	1998-11-13	Association riluzole et alpha-tocopherol
PCT/FR1999/002753 WO2000028992A1 (fr)	1998-11-13	1999-11-09	Association riluzole et alpha-tocopherol

Publications (1)

Publication Number	Publication Date
ATE295168T1 true ATE295168T1 (de)	2005-05-15

Family

ID=9532674

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99972101T ATE295168T1 (de)	1998-11-13	1999-11-09	Zusammensetzung von riluzol und alpha-tocopherol

Country Status (23)

Country	Link
US (2)	US6642262B2 (de)
EP (1)	EP1128829B1 (de)
JP (1)	JP4693241B2 (de)
KR (1)	KR100641472B1 (de)
CN (1)	CN1177587C (de)
AT (1)	ATE295168T1 (de)
AU (1)	AU776242B2 (de)
BR (1)	BR9915292A (de)
CA (1)	CA2350671C (de)
CZ (1)	CZ298808B6 (de)
DE (1)	DE69925301T2 (de)
DK (1)	DK1128829T3 (de)
EA (1)	EA003671B1 (de)
ES (1)	ES2239858T3 (de)
FR (1)	FR2785808B1 (de)
HK (1)	HK1041220B (de)
HU (1)	HU226067B1 (de)
IL (1)	IL142708A0 (de)
NO (1)	NO328349B1 (de)
PT (1)	PT1128829E (de)
TR (1)	TR200101346T2 (de)
WO (1)	WO2000028992A1 (de)
ZA (1)	ZA200103810B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2786101B1 (fr) *	1998-11-24	2002-07-05	Aventis Laboratoire	Utilisation de la nicergoline dans le traitement de la spasticite
WO2007046347A1 (ja) *	2005-10-18	2007-04-26	Ono Pharmaceutical Co., Ltd.	筋萎縮性側索硬化症患者の運動神経保護用医薬
US20070099156A1 (en) *	2005-10-28	2007-05-03	Jeff Wagner	Self-etching dental primer compositions and methods and systems utilizing such compositions
FR2957077B1 (fr)	2010-03-02	2012-04-13	Univ Dauvergne Clermont I	Utilisation du riluzole pour traiter ou prevenir les effets indesirables d'agents anti-cancereux
WO2014145776A2 (en) *	2013-03-15	2014-09-18	Baylor College Of Medicine	Msp and its receptors in the therapy of amyotrophic lateral sclerosis
CN114344297B (zh) *	2022-03-01	2024-05-14	暨南大学	利鲁唑在治疗少精症中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2688138B1 (fr) *	1992-03-06	1995-05-05	Rhone Poulenc Rorer Sa	Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique.
US5843641A (en) *	1993-02-26	1998-12-01	Massachusetts Institute Of Technology	Methods for the daignosis, of familial amyotrophic lateral sclerosis
US6380252B1 (en) *	1996-07-05	2002-04-30	Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.	Use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine for increasing the levels of IGF-1
US5780489A (en) *	1996-08-21	1998-07-14	Brooks; Benjamin Rix	Method for treating amyotrophic lateral sclerosis
JP3889844B2 (ja) *	1997-02-10	2007-03-07	龍兒梶	筋萎縮性側索硬化症治療剤
FR2782008B1 (fr) *	1998-08-07	2003-04-25	Sod Conseils Rech Applic	Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sclerose laterale amyotrophique

1998
- 1998-11-13 FR FR9814250A patent/FR2785808B1/fr not_active Expired - Fee Related
1999
- 1999-11-09 ES ES99972101T patent/ES2239858T3/es not_active Expired - Lifetime
- 1999-11-09 KR KR1020017005912A patent/KR100641472B1/ko not_active Expired - Fee Related
- 1999-11-09 DK DK99972101T patent/DK1128829T3/da active
- 1999-11-09 HK HK02102998.6A patent/HK1041220B/zh not_active IP Right Cessation
- 1999-11-09 CN CNB998131903A patent/CN1177587C/zh not_active Expired - Fee Related
- 1999-11-09 BR BR9915292-4A patent/BR9915292A/pt not_active Application Discontinuation
- 1999-11-09 EA EA200100530A patent/EA003671B1/ru not_active IP Right Cessation
- 1999-11-09 CA CA2350671A patent/CA2350671C/fr not_active Expired - Fee Related
- 1999-11-09 TR TR2001/01346T patent/TR200101346T2/xx unknown
- 1999-11-09 PT PT99972101T patent/PT1128829E/pt unknown
- 1999-11-09 JP JP2000582039A patent/JP4693241B2/ja not_active Expired - Fee Related
- 1999-11-09 EP EP99972101A patent/EP1128829B1/de not_active Expired - Lifetime
- 1999-11-09 DE DE69925301T patent/DE69925301T2/de not_active Expired - Lifetime
- 1999-11-09 CZ CZ20011561A patent/CZ298808B6/cs not_active IP Right Cessation
- 1999-11-09 IL IL14270899A patent/IL142708A0/xx not_active IP Right Cessation
- 1999-11-09 AU AU11655/00A patent/AU776242B2/en not_active Ceased
- 1999-11-09 WO PCT/FR1999/002753 patent/WO2000028992A1/fr not_active Ceased
- 1999-11-09 AT AT99972101T patent/ATE295168T1/de active
- 1999-11-09 HU HU0105301A patent/HU226067B1/hu not_active IP Right Cessation
2001
- 2001-05-10 ZA ZA200103810A patent/ZA200103810B/en unknown
- 2001-05-10 NO NO20012308A patent/NO328349B1/no not_active IP Right Cessation
- 2001-05-11 US US09/854,318 patent/US6642262B2/en not_active Expired - Lifetime
2003
- 2003-02-18 US US10/369,151 patent/US20030125363A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20030125363A1 (en)	2003-07-03
KR20010080407A (ko)	2001-08-22
HUP0105301A3 (en)	2006-07-28
TR200101346T2 (tr)	2002-05-21
DK1128829T3 (da)	2005-08-29
FR2785808A1 (fr)	2000-05-19
NO328349B1 (no)	2010-02-01
EP1128829A1 (de)	2001-09-05
HK1041220B (zh)	2005-07-22
ZA200103810B (en)	2002-08-12
ES2239858T3 (es)	2005-10-01
EA200100530A1 (ru)	2001-10-22
HU226067B1 (en)	2008-04-28
US6642262B2 (en)	2003-11-04
AU776242B2 (en)	2004-09-02
AU1165500A (en)	2000-06-05
EA003671B1 (ru)	2003-08-28
CN1326348A (zh)	2001-12-12
US20020019426A1 (en)	2002-02-14
WO2000028992A1 (fr)	2000-05-25
NO20012308D0 (no)	2001-05-10
EP1128829B1 (de)	2005-05-11
PT1128829E (pt)	2005-07-29
CN1177587C (zh)	2004-12-01
BR9915292A (pt)	2001-08-07
KR100641472B1 (ko)	2006-10-31
JP4693241B2 (ja)	2011-06-01
CZ20011561A3 (cs)	2001-08-15
CA2350671A1 (fr)	2000-05-25
HK1041220A1 (en)	2002-07-05
FR2785808B1 (fr)	2002-12-06
IL142708A0 (en)	2002-03-10
JP2002529506A (ja)	2002-09-10
CA2350671C (fr)	2010-05-04
HUP0105301A2 (hu)	2002-05-29
DE69925301D1 (de)	2005-06-16
NO20012308L (no)	2001-05-10
DE69925301T2 (de)	2006-01-26
CZ298808B6 (cs)	2008-02-06

Legal Events

Date

Code

Title

Description

2006-04-15

UEP

Publication of translation of european patent specification

Ref document number: 1128829

Country of ref document: EP

Publication	Publication Date	Title
DK1214936T3 (da)	2004-12-06	Anvendelse af thiazolidin- eller pyrrolidinderivater af aminosyrer som antihyperglykæmiske midler
DK0797439T3 (da)	2003-08-25	Anvendelse af pramipexol som et neurobeskyttende middel
EA199800667A1 (ru)	1999-02-25	Новые фенантридины
NO912630L (no)	1992-01-06	Fremgangsmaate for fremstilling av nye 2,6-dialkyl-4-silyl-fenoler som antiarteriosklerotiske midler
ES2114487B1 (es)	1999-04-01	Mezcla estabilizante sinergistica.
ES2127397T3 (es)	1999-04-16	Sulfonamidas y sus derivados que modulan la actividad de la endotelina.
ATE225772T1 (de)	2002-10-15	Thrombin-inhibitoren
ATE196761T1 (de)	2000-10-15	Inhibitoren retroviraler proteasen
BR0317715A (pt)	2005-11-22	Composições e processos de uso de collajolie
FI20085256L (fi)	2008-03-28	Retrovirusperäisten proteaasi-inhibiittoreiden yhdistelmä
AU6613896A (en)	1996-10-30	Chemical compounds
TR199701654T1 (xx)	1998-05-21	4-Fenilaminotiyazol t�revleri.
ATE448774T1 (de)	2009-12-15	Kosmetische zusammensetzung enthaltend ein siegesbeckia extrakt und ein lipopeptid
DE69935873D1 (de)	2007-05-31	2-Methyl-thieno-benzodiazepin Formulierung
ES2168816T3 (es)	2002-06-16	Cemento de inyeccion que contiene inhibidores de la corrosion.
DE69925301D1 (de)	2005-06-16	Zusammensetzung von riluzol und alpha-tocopherol
DE60121048D1 (de)	2006-08-03	PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
DK1073447T3 (da)	2007-09-03	N1-modificerede glycopeptider
SE9704770D0 (sv)	1997-12-19	New use
IL127930A0 (en)	1999-11-30	Verapamil as a medicament for the treatment of angina
DK0673913T3 (da)	1999-09-20	Calcium-alkalimetalcitratforbindelser samt deres anvendelse som lægemidler
FR2778102B1 (fr)	2001-04-06	Utilisation d'oligomeres procyanidoliques (opc) ou d'anthocyanosides a titre d'agents anti-urease
DK0828483T3 (da)	2003-05-19	Anvendelse af tropolonderivater som inhibitorer af enzymet inositolmonophosphatase
SE9303060D0 (sv)	1993-09-19	Löstagbar stoppanordning
ECSP972052A (es)	1998-02-13	Quinoxalinadionas